Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica

JAMA

Volumn 281, Issue 9, 1999, Pages 811-817

  Steffen, Robert ^a,i   Collard, Françoise ^b   Tornieporth, Nadia ^b,c   Campbell Forrester, Sheila ^d   Ashley, David ^d   Thompson, Sharon ^e   Mathewson, John J ^f   Maes, Edith ^g   Stephenson, Barbara ^h   DuPont, Herbert L ^j   Von Sonnenburg, Frank ^c  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^c UNIVERSITY OF MUNICH   (Germany)

^d Ministry of Health of Jamaica   (Jamaica)

^e Ministry of Health   (Jamaica)

^f UNIVERSITY OF TEXAS   (United States)

^g Lewin Group   (Belgium)

^h MCMASTER UNIVERSITY   (Canada)

ⁱ UNIVERSITY OF ZURICH   (Switzerland)

^j NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI ENTEROTOXIN;

ADOLESCENT; ADULT; ARTICLE; FECES ANALYSIS; FEMALE; HUMAN; INCIDENCE; JAMAICA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; ROTAVIRUS; SALMONELLA; TRAVELLER DIARRHEA;

EID: 0033518842     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.281.9.811     Document Type: Article

References (28)

1. DuPont HL, Ericsson CD. Prevention and treatment of travelers' diarrhea. N Engl J Med. 1993;328: 1821-1827.
2. World Health Organization. The World Health Report 1996: Report of the Director-General. Geneva, Switzerland: World Health Organization; 1996:5.
3. Steffen R, Van der Linde F, Gyr K, Schär M. Epidemiology of diarrhea in travelers. JAMA. 1983;249: 1176-1180.
4. Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be warrant adoption and utilization? CMAJ. 1992;146:473-481.
5. Guyatt GH, Van Zanten SJOV, Feeny DH, Patrick DL. Measuring quality of life in clinical trials: a taxonomy and review. CMAJ. 1989;140:1441-1448.
6. Svennerholm A-M, Holmgren J. Oral vaccines against cholera and enterotoxigenic E coli diarrhea. Adv Exp Med Biol. 1995;371B:1623-1628.
7. Holmgren J, Svennerholm A-M. New vaccines against bacterial enteric infections. Scand J Infect Dis. 1990;70(suppl):149-156.
8. Stucki A. Epidemiologie der Reisediarrhoe bei Touristen in Jamaica 1995 [thesis]. Zurich, Switzerland: University of Zurich; 1997.
9. Mathewson J, Oberhelman RA, Du Pont HL, de la Cabala FJ, Garibay EV. Enteroadherent Escherichia coli as a cause of diarrhea among children in Mexico. J Clin Microbiol. 1987;25:1917-1919.
10. Ryan NJ, Sutherland G, Couglan K, et al. A new trichrome-blue stain for the detection of microsporidial species in urine, stool, and nasopharyngeal specimens. J Clin Microbiol. 1993;31:3264-3269.
11. Berlin OG, Novak SM, Porschen RK, Long EG, Stelma GN, Schaeffer FW. Recovery of Cyclospora organism from patients with prolonged diarrhea. Clin Infect Dis. 1994;18:606-609.
12. Murray BE, Mathewson JJ, DuPont HL, Hill WE. Utility of oligodesoxyribonucleotide probes for detecting enterotoxigenic Escherichia coli. J Infect Dis. 1987;155:809-811.
13. Viboud GI, Binsztein N, Svennerholm A-M. Characterization of monoclonal antibodies against putative colonization factors of enterotoxigenic Escherichia coli and their use in an epidemiological study. J Clin Microbiol. 1993;31:558-564.
14. Guyatt GH, Mitchell A, Irvine EJ, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989;96:804-810.
15. Mitchell A, Guyatt GH, Singer J, et al. Quality of life in patients with inflammatory bowel disease. J Clin Gastroenterol. 1988;10:306-310.
16. Canadian Coordinating Office for Health Technology Assessment. Guidelines for Economic Evaluation of Pharmaceutical: Canada. Ottawa, Ontario: Canadian Coordinating Office for Health Technology Assessment; 1994.
17. DuPont HL, Pickering LK. Infections of the gastrointestinal tract. In: Microbiology, Pathophysiology, and Clinical Features. New York, NY: Plenum Publishing Corp; 1980:219.
18. Pickering LK, DuPont HL, Evans DG, Evans DJJ, Olarte J. Isolation of enteric pathogens from asymptomatic students from the United States and Latin America. J Infect Dis. 1977;135:1003-1005.
19. Farthing MJG, DuPont HL, Guandalini S, Keusch G, Steffen R. Treatment and prevention of travellers' diarrhea. Gastroenterol Int. 1993;5:162-175.
20. Cartwright RY. Epidemiology of travellers' diarrhoea in British package holiday tourists. Public Health Lab Serv Microbiol Digest. 1992;9:121-124.
21. Cartwright RY, Chahed M. Foodborne diseases in travellers. World Health Stat Q. 1997;50:102-110.
22. Kozicki M, Steffen R, Schär M. Boil it, cook it, peel it, or forget it. Int J Epidemiol. 1985;14:169-172.
23. Mattila L, Siitonen A, Kyronseppa H, Simula I, Peltola H. Risk behavior for travelers' diarrhea among Finnish travelers. J Travel Med. 1995;2:77-84.
24. Beecham HJ III, Lebron CI, Echeverria P. Short report. Am J Trop Med Hyg. 1997;57:699-701.
25. Black R. Epidemiology of travelers' diarrhea and relative importation of various pathogens. Rev Infect Dis. 1990;12(suppl 1):S73-S79.
26. Peredes P, Campbell-Forrester S, Mathewson JJ, et al. The etiology of travelers' diarrhea on a Caribbean island. J Travel Med. In press.
27. Peltola H, Siitonen A, Kyronseppa H. Prevention of travellers' diarrhea by oral B-subunit/whole-cell cholera vaccine. Lancet. 1991;338:1285-1289.
28. Steffen R, Kane MA, Shapiro CN, Schoellhorn JK, Van Damme P. Epidemiology and prevention of hepatitis A in travelers. JAMA. 1994;272:885-889.